Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:19571879  

Telomerase modulates Wnt signalling by association with target gene chromatin.

Jae-Il Park | Andrew S Venteicher | Ji Yeon Hong | Jinkuk Choi | Sohee Jun | Marina Shkreli | Woody Chang | Zhaojing Meng | Peggie Cheung | Hong Ji | Margaret McLaughlin | Timothy D Veenstra | Roel Nusse | Pierre D McCrea | Steven E Artandi
Nature | 2009

Stem cells are controlled, in part, by genetic pathways frequently dysregulated during human tumorigenesis. Either stimulation of Wnt/beta-catenin signalling or overexpression of telomerase is sufficient to activate quiescent epidermal stem cells in vivo, although the mechanisms by which telomerase exerts these effects are not understood. Here we show that telomerase directly modulates Wnt/beta-catenin signalling by serving as a cofactor in a beta-catenin transcriptional complex. The telomerase protein component TERT (telomerase reverse transcriptase) interacts with BRG1 (also called SMARCA4), a SWI/SNF-related chromatin remodelling protein, and activates Wnt-dependent reporters in cultured cells and in vivo. TERT serves an essential role in formation of the anterior-posterior axis in Xenopus laevis embryos, and this defect in Wnt signalling manifests as homeotic transformations in the vertebrae of Tert(-/-) mice. Chromatin immunoprecipitation of the endogenous TERT protein from mouse gastrointestinal tract shows that TERT physically occupies gene promoters of Wnt-dependent genes. These data reveal an unanticipated role for telomerase as a transcriptional modulator of the Wnt/beta-catenin signalling pathway.

Pubmed ID: 19571879

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA111691
  • Agency: NCI NIH HHS, United States
    Id: R01 CA125453
  • Agency: NCI NIH HHS, United States
    Id: P30 CA124435
  • Agency: NCI NIH HHS, United States
    Id: CA125453
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM052112
  • Agency: NCI NIH HHS, United States
    Id: CA111691

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.